vs
Side-by-side financial comparison of SBC Medical Group Holdings Inc (SBC) and Snail, Inc. (SNAL). Click either name above to swap in a different company.
SBC Medical Group Holdings Inc is the larger business by last-quarter revenue ($39.6M vs $25.1M, roughly 1.6× Snail, Inc.). SBC Medical Group Holdings Inc runs the higher net margin — 35.9% vs -3.4%, a 39.3% gap on every dollar of revenue. On growth, Snail, Inc. posted the faster year-over-year revenue change (-4.2% vs -10.9%). Over the past eight quarters, Snail, Inc.'s revenue compounded faster (33.4% CAGR vs -15.0%).
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
Suzhou Snail Digital Technology Co., Ltd., doing business as Snail, is a Chinese video game company and a Virtual Network Operator headquartered in Suzhou, China, which has branches Snail Games and Snail Mobile. Its division, Snail USA, markets Snail Games products in North America, South America, & Europe. Snail Games products include massively multiplayer online (MMOs), real-time strategy (RTS), and casual games. Its global registered user base has reached over 70 million accounts. The U.S....
SBC vs SNAL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $39.6M | $25.1M |
| Net Profit | $14.2M | $-862.2K |
| Gross Margin | 73.1% | 38.3% |
| Operating Margin | 32.5% | -6.0% |
| Net Margin | 35.9% | -3.4% |
| Revenue YoY | -10.9% | -4.2% |
| Net Profit YoY | 117.2% | -177.0% |
| EPS (diluted) | $0.15 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $39.6M | $25.1M | ||
| Q3 25 | $43.4M | $13.8M | ||
| Q2 25 | $43.4M | $22.2M | ||
| Q1 25 | $47.3M | $20.1M | ||
| Q4 24 | $44.4M | $26.2M | ||
| Q3 24 | $53.1M | $22.5M | ||
| Q2 24 | $53.1M | $21.6M | ||
| Q1 24 | $54.8M | $14.1M |
| Q4 25 | $14.2M | $-862.2K | ||
| Q3 25 | $12.8M | $-7.9M | ||
| Q2 25 | $2.5M | $-16.6M | ||
| Q1 25 | $21.5M | $-1.9M | ||
| Q4 24 | $6.5M | $1.1M | ||
| Q3 24 | $2.8M | $235.1K | ||
| Q2 24 | $18.5M | $2.3M | ||
| Q1 24 | $18.8M | $-1.8M |
| Q4 25 | 73.1% | 38.3% | ||
| Q3 25 | 70.6% | 0.1% | ||
| Q2 25 | 69.2% | 31.3% | ||
| Q1 25 | 79.7% | 29.1% | ||
| Q4 24 | 76.3% | 43.3% | ||
| Q3 24 | 81.5% | 38.6% | ||
| Q2 24 | 74.2% | 37.5% | ||
| Q1 24 | 72.1% | 14.7% |
| Q4 25 | 32.5% | -6.0% | ||
| Q3 25 | 36.6% | -71.3% | ||
| Q2 25 | 33.6% | -8.2% | ||
| Q1 25 | 51.1% | -20.4% | ||
| Q4 24 | 10.6% | 11.5% | ||
| Q3 24 | 26.1% | 1.8% | ||
| Q2 24 | 51.4% | 12.4% | ||
| Q1 24 | 44.6% | -15.6% |
| Q4 25 | 35.9% | -3.4% | ||
| Q3 25 | 29.6% | -56.9% | ||
| Q2 25 | 5.7% | -74.7% | ||
| Q1 25 | 45.4% | -9.7% | ||
| Q4 24 | 14.7% | 4.3% | ||
| Q3 24 | 5.3% | 1.0% | ||
| Q2 24 | 34.8% | 10.4% | ||
| Q1 24 | 34.2% | -12.6% |
| Q4 25 | $0.15 | — | ||
| Q3 25 | $0.12 | — | ||
| Q2 25 | $0.02 | $-0.44 | ||
| Q1 25 | $0.21 | $-0.06 | ||
| Q4 24 | $0.05 | $0.03 | ||
| Q3 24 | $0.03 | $0.01 | ||
| Q2 24 | $0.20 | $0.06 | ||
| Q1 24 | $0.20 | $-0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $164.1M | $8.6M |
| Total DebtLower is stronger | $42.8M | $14.6M |
| Stockholders' EquityBook value | $248.3M | $-16.4M |
| Total Assets | $380.4M | $59.3M |
| Debt / EquityLower = less leverage | 0.17× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $164.1M | $8.6M | ||
| Q3 25 | $127.4M | $12.3M | ||
| Q2 25 | $152.7M | $7.9M | ||
| Q1 25 | $132.1M | $9.4M | ||
| Q4 24 | $125.0M | $7.3M | ||
| Q3 24 | $137.4M | $10.6M | ||
| Q2 24 | — | $15.5M | ||
| Q1 24 | — | $16.1M |
| Q4 25 | $42.8M | $14.6M | ||
| Q3 25 | $21.1M | $10.5M | ||
| Q2 25 | $7.1M | $11.8M | ||
| Q1 25 | $6.9M | $9.0M | ||
| Q4 24 | $6.6M | $5.7M | ||
| Q3 24 | $823.2K | $5.7M | ||
| Q2 24 | — | $5.8M | ||
| Q1 24 | — | $6.5M |
| Q4 25 | $248.3M | $-16.4M | ||
| Q3 25 | $248.0M | $-15.6M | ||
| Q2 25 | $244.6M | $-8.0M | ||
| Q1 25 | $226.4M | $9.1M | ||
| Q4 24 | $195.1M | $9.7M | ||
| Q3 24 | $205.0M | $8.2M | ||
| Q2 24 | $8.8M | $7.9M | ||
| Q1 24 | $9.0M | $5.6M |
| Q4 25 | $380.4M | $59.3M | ||
| Q3 25 | $321.4M | $51.1M | ||
| Q2 25 | $315.3M | $58.0M | ||
| Q1 25 | $284.6M | $64.5M | ||
| Q4 24 | $266.1M | $62.2M | ||
| Q3 24 | $296.5M | $66.8M | ||
| Q2 24 | $19.5M | $75.4M | ||
| Q1 24 | $19.8M | $78.3M |
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.09× | — | ||
| Q2 25 | 0.03× | — | ||
| Q1 25 | 0.03× | 0.99× | ||
| Q4 24 | 0.03× | 0.59× | ||
| Q3 24 | 0.00× | 0.70× | ||
| Q2 24 | — | 0.73× | ||
| Q1 24 | — | 1.16× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $52.0M | $-5.3M |
| Free Cash FlowOCF − Capex | $51.2M | — |
| FCF MarginFCF / Revenue | 129.3% | — |
| Capex IntensityCapex / Revenue | 2.0% | — |
| Cash ConversionOCF / Net Profit | 3.66× | — |
| TTM Free Cash FlowTrailing 4 quarters | $23.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $52.0M | $-5.3M | ||
| Q3 25 | $-20.9M | $6.6M | ||
| Q2 25 | $-8.3M | $-3.2M | ||
| Q1 25 | $1.9M | $764.5K | ||
| Q4 24 | $-7.3M | $-3.6M | ||
| Q3 24 | $5.0M | $-5.0M | ||
| Q2 24 | $19.2M | $206.6K | ||
| Q1 24 | $3.7M | $6.8M |
| Q4 25 | $51.2M | — | ||
| Q3 25 | $-20.9M | — | ||
| Q2 25 | $-8.6M | — | ||
| Q1 25 | $1.7M | — | ||
| Q4 24 | $-7.9M | — | ||
| Q3 24 | $4.6M | — | ||
| Q2 24 | $18.3M | — | ||
| Q1 24 | $3.0M | — |
| Q4 25 | 129.3% | — | ||
| Q3 25 | -48.3% | — | ||
| Q2 25 | -19.9% | — | ||
| Q1 25 | 3.5% | — | ||
| Q4 24 | -17.8% | — | ||
| Q3 24 | 8.7% | — | ||
| Q2 24 | 34.5% | — | ||
| Q1 24 | 5.4% | — |
| Q4 25 | 2.0% | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.7% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 1.3% | — | ||
| Q3 24 | 0.8% | — | ||
| Q2 24 | 1.6% | — | ||
| Q1 24 | 1.3% | — |
| Q4 25 | 3.66× | — | ||
| Q3 25 | -1.63× | — | ||
| Q2 25 | -3.39× | — | ||
| Q1 25 | 0.09× | — | ||
| Q4 24 | -1.12× | -3.21× | ||
| Q3 24 | 1.77× | -21.05× | ||
| Q2 24 | 1.04× | 0.09× | ||
| Q1 24 | 0.20× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
SNAL
| Pc | $14.7M | 59% |
| Platform Three | $5.2M | 21% |
| Platform Two | $3.3M | 13% |
| Sales Channel Directly To Consumer Mobile Sale | $1.6M | 6% |
